Works matching AU Azuma, Koichi


Results: 122
    1
    2
    3

    Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 8, p. 661, doi. 10.1016/j.cllc.2024.07.001
    By:
    • Yosuke Kakiuchi;
    • Koichi Saruwatari;
    • Kenta Murotani;
    • Takaaki Tokito;
    • Toyohisa Iriki;
    • Jun Iwakawa;
    • Yoshihiko Sakata;
    • Naoki Shingu;
    • Sho Saeki;
    • Megumi Inaba;
    • Akira Takaki;
    • Shunsuke Misono;
    • Takayuki Suetsugu;
    • Koichi Azuma;
    • Keiko Mizuno;
    • Takuro Sakagami
    Publication type:
    Article
    4

    Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 6, p. 519, doi. 10.1016/j.cllc.2023.05.008
    By:
    • Kimio Yonesaka;
    • Hidetoshi Hayashi;
    • Atsushi Nakamura;
    • Yuki Sato;
    • Koichi Azuma;
    • Shinya Sakata;
    • Motoko Tachihara;
    • Satoshi Ikeda;
    • Toshihide Yokoyama;
    • Kentaro Ito;
    • Yukihiro Yano;
    • Hirotaka Matsumoto;
    • Haruko Daga;
    • Akito Hata;
    • Kazuko Sakai;
    • Yasutaka Chiba;
    • Kazuto Nishio;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawal
    Publication type:
    Article
    5

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    6

    Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    2020
    By:
    • Shiraishi, Yoshimasa;
    • Kishimoto, Junji;
    • Tanaka, Kentaro;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirano, Katsuya;
    • Azuma, Koichi;
    • Hataji, Osamu;
    • Hayashi, Hidetoshi;
    • Tachihara, Motoko;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Okamoto, Isamu
    Publication type:
    journal article
    7
    8
    9
    10

    First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 452, doi. 10.1093/jjco/hyad195
    By:
    • Imai, Hisao;
    • Kijima, Takashi;
    • Azuma, Koichi;
    • Kishi, Kazuma;
    • Saito, Haruhiro;
    • Yamaguchi, Teppei;
    • Tanizaki, Junko;
    • Yoneshima, Yasuto;
    • Fujita, Kohei;
    • Watanabe, Satoshi;
    • Kitazono, Satoru;
    • Fukuhara, Tatsuro;
    • Hataji, Osamu;
    • Toi, Yukihiro;
    • Mizutani, Hideaki;
    • Hamakawa, Yusuke;
    • Maemondo, Makoto;
    • Ohsugi, Tomoyuki;
    • Suzuki, Keisuke;
    • Horinouchi, Hidehito
    Publication type:
    Article
    11

    Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C.

    Published in:
    Annals of Gastroenterology & Hepatology, 2010, v. 8, n. 88, p. 4400, doi. 10.3748/wjg.v16.i35.4400
    By:
    • Mosaburo Kainuma;
    • Norihiro Furusyo;
    • Eiji Kajiwara;
    • Kazuhiro Takahashi;
    • Hideyuki Nomura;
    • Yuichi Tanabe;
    • Takeaki Satoh;
    • Toshihiro Maruyama;
    • Makoto Nakamuta;
    • Kazuhiro Kotoh;
    • Koichi Azuma;
    • Junya Shimono;
    • Shinji Shimoda;
    • Jun Hayashi
    Publication type:
    Article
    12
    13

    Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2639, doi. 10.1007/s00432-020-03250-6
    By:
    • Takada, Kazuki;
    • Toyokawa, Gouji;
    • Kinoshita, Fumihiko;
    • Jogo, Tomoko;
    • Kohashi, Kenichi;
    • Wakasu, Sho;
    • Ono, Yuki;
    • Tanaka, Kensuke;
    • Oba, Taro;
    • Osoegawa, Atsushi;
    • Tagawa, Tetsuzo;
    • Azuma, Koichi;
    • Okamoto, Isamu;
    • Shimokawa, Mototsugu;
    • Oda, Yoshinao;
    • Mori, Masaki
    Publication type:
    Article
    14
    15
    16

    Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1699, doi. 10.1007/s00262-023-03370-1
    By:
    • Morimoto, Kenji;
    • Yamada, Tadaaki;
    • Sawada, Ryo;
    • Azuma, Koichi;
    • Goto, Yasuhiro;
    • Harada, Taishi;
    • Shiotsu, Shinsuke;
    • Tamiya, Nobuyo;
    • Chihara, Yusuke;
    • Takeda, Takayuki;
    • Hiranuma, Osamu;
    • Hasegawa, Isao;
    • Tanaka, Satomi;
    • Yoshimura, Akihiro;
    • Iwasaku, Masahiro;
    • Tokuda, Shinsaku;
    • Kim, Young Hak;
    • Takayama, Koichi
    Publication type:
    Article
    17
    18
    19
    20

    Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 713, doi. 10.1111/apt.17107
    By:
    • Ogawa, Eiichi;
    • Nakamuta, Makoto;
    • Koyanagi, Toshimasa;
    • Ooho, Aritsune;
    • Furusyo, Norihiro;
    • Kajiwara, Eiji;
    • Dohmen, Kazufumi;
    • Kawano, Akira;
    • Satoh, Takeaki;
    • Takahashi, Kazuhiro;
    • Azuma, Koichi;
    • Yamashita, Nobuyuki;
    • Yamashita, Naoki;
    • Sugimoto, Rie;
    • Amagase, Hiromasa;
    • Kuniyoshi, Masami;
    • Ichiki, Yasunori;
    • Morita, Chie;
    • Kato, Masaki;
    • Shimoda, Shinji
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.

    Published in:
    2016
    By:
    • Takeda, Masayuki;
    • Yamanaka, Takeharu;
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Azuma, Koichi;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirashima, Tomonori;
    • Yonesaka, Kimio;
    • Urata, Yoshiko;
    • Murakami, Haruyasu;
    • Saito, Haruhiro;
    • Kubo, Akihito;
    • Sawa, Toshiyuki;
    • Miyahara, Eiji;
    • Nogami, Naoyuki;
    • Nakagawa, Kazuhiko;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    journal article
    29
    30

    Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study.

    Published in:
    Hepatology Research, 2019, v. 49, n. 6, p. 617, doi. 10.1111/hepr.13328
    By:
    • Ogawa, Eiichi;
    • Furusyo, Norihiro;
    • Nakamuta, Makoto;
    • Nomura, Hideyuki;
    • Satoh, Takeaki;
    • Takahashi, Kazuhiro;
    • Koyanagi, Toshimasa;
    • Kajiwara, Eiji;
    • Dohmen, Kazufumi;
    • Kawano, Akira;
    • Ooho, Aritsune;
    • Azuma, Koichi;
    • Kato, Masaki;
    • Shimoda, Shinji;
    • Hayashi, Jun
    Publication type:
    Article
    31

    Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis.

    Published in:
    Hepatology Research, 2017, v. 47, n. 3, p. E120, doi. 10.1111/hepr.12738
    By:
    • Ogawa, Eiichi;
    • Furusyo, Norihiro;
    • Yamashita, Naoki;
    • Kawano, Akira;
    • Takahashi, Kazuhiro;
    • Dohmen, Kazufumi;
    • Nakamuta, Makoto;
    • Satoh, Takeaki;
    • Nomura, Hideyuki;
    • Azuma, Koichi;
    • Koyanagi, Toshimasa;
    • Kotoh, Kazuhiro;
    • Shimoda, Shinji;
    • Kajiwara, Eiji;
    • Hayashi, Jun
    Publication type:
    Article
    32

    Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C.

    Published in:
    Hepatology Research, 2016, v. 46, n. 3, p. E174, doi. 10.1111/hepr.12555
    By:
    • Ikezaki, Hiroaki;
    • Nomura, Hideyuki;
    • Furusyo, Norihiro;
    • Ogawa, Eiichi;
    • Kajiwara, Eiji;
    • Takahashi, Kazuhiro;
    • Kawano, Akira;
    • Maruyama, Toshihiro;
    • Tanabe, Yuichi;
    • Satoh, Takeaki;
    • Nakamuta, Makoto;
    • Kotoh, Kazuhiro;
    • Azuma, Koichi;
    • Dohmen, Kazufumi;
    • Shimoda, Shinji;
    • Hayashi, Jun
    Publication type:
    Article
    33
    34
    35

    Ambulatory Blood Pressure Variability Is Increased in Diabetic Hypertensives.

    Published in:
    Clinical & Experimental Hypertension, 2008, v. 30, n. 3/4, p. 213, doi. 10.1080/10641960802068477
    By:
    • Ozawa, Motoko;
    • Tamura, Kouichi;
    • Iwatsubo, Kousaku;
    • Matsushita, Kouhei;
    • Sakai, Masashi;
    • Tsurumi-Ikeya, Yuko;
    • Azuma, Koichi;
    • Shigenaga, Atsuichiro;
    • Okano, Yasuko;
    • Masuda, Shinichiro;
    • Wakui, Hiromichi;
    • Ishigami, Tomoaki;
    • Umemura, Satoshi
    Publication type:
    Article
    36

    Ambulatory Blood Pressure and Heart Rate in Hypertensives with Renal Failure: Comparison between Diabetic Nephropathy and Non-Diabetic Glomerulopathy.

    Published in:
    Clinical & Experimental Hypertension, 2008, v. 30, n. 1, p. 33, doi. 10.1080/10641960701813890
    By:
    • Tamura, Kouichi;
    • Yamauchi, Junji;
    • Tsurumi-Ikeya, Yuko;
    • Sakai, Masashi;
    • Ozawa, Motoko;
    • Shigenaga, Atsuichiro;
    • Azuma, Koichi;
    • Okano, Yasuko;
    • Ishigami, Tomoaki;
    • Toya, Yoshiyuki;
    • Yabana, Machiko;
    • Tokita, Yasuo;
    • Ohnishi, Toshimasa;
    • Umemura, Satoshi
    Publication type:
    Article
    37
    38
    39
    40
    41

    Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.

    Published in:
    Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820
    By:
    • Iwama, Eiji;
    • Sakai, Kazuko;
    • Azuma, Koichi;
    • Harada, Daijiro;
    • Nosaki, Kaname;
    • Hotta, Katsuyuki;
    • Nishio, Makoto;
    • Kurata, Takayasu;
    • Fukuhara, Tatsuro;
    • Akamatsu, Hiroaki;
    • Goto, Koichi;
    • Shimose, Takayuki;
    • Kishimoto, Junji;
    • Nakanishi, Yoichi;
    • Nishio, Kazuto;
    • Okamoto, Isamu
    Publication type:
    Article
    42

    Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations.

    Published in:
    Cancer Science, 2018, v. 109, n. 9, p. 2852, doi. 10.1111/cas.13724
    By:
    • Murakami, Haruyasu;
    • Nokihara, Hiroshi;
    • Hayashi, Hidetoshi;
    • Seto, Takashi;
    • Park, Keunchil;
    • Azuma, Koichi;
    • Tsai, Chun‐Ming;
    • Yang, James Chih‐Hsin;
    • Nishio, Makoto;
    • Kim, Sang‐We;
    • Kiura, Katsuyuki;
    • Inoue, Akira;
    • Takeda, Koji;
    • Kang, Jin‐Hyoung;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Akazawa, Rio;
    • Kaneko, Yuichiro;
    • Shimazaki, Masashi;
    • Morita, Satoshi
    Publication type:
    Article
    43

    ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

    Published in:
    Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651
    By:
    • Azuma, Koichi;
    • Nishio, Makoto;
    • Hayashi, Hidetoshi;
    • Kiura, Katsuyuki;
    • Satouchi, Miyako;
    • Sugawara, Shunichi;
    • Hida, Toyoaki;
    • Iwamoto, Yasuo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Ikeda, Satoshi;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Asahina, Seitaro;
    • Komatsu, Kanji;
    • Morita, Satoshi;
    • Fukuoka, Masahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 12, p. 1759, doi. 10.1111/jgh.13016
    By:
    • Ogawa, Eiichi;
    • Furusyo, Norihiro;
    • Kajiwara, Eiji;
    • Nomura, Hideyuki;
    • Kawano, Akira;
    • Takahashi, Kazuhiro;
    • Dohmen, Kazufumi;
    • Satoh, Takeaki;
    • Azuma, Koichi;
    • Nakamuta, Makoto;
    • Koyanagi, Toshimasa;
    • Kotoh, Kazuhiro;
    • Shimoda, Shinji;
    • Hayashi, Jun
    Publication type:
    Article
    50